Navigation Links
PDI Reports 2009 Second Quarter Financial Results
Date:8/5/2009

sociated with the retirement of our former Chief Executive Officer in 2008, 2009 operating expenses were $1.0 million, or 9%, lower than 2008. This decline is primarily attributable to the Company's ongoing cost-reduction initiatives.

Other income, which is primarily interest income, declined by $0.7 million in 2009 compared to 2008 due to a combination of lower available cash and cash equivalents and the Company's more conservative investing practices in 2009 compared to 2008.

Total operating loss for the second quarter of 2009 was $4.7 million compared to $7.9 million in the same period of 2008. Net loss per share for the second quarter of 2009 was $0.34 compared to $0.52 in 2008.

Cash and cash equivalents as of June 30, 2009 were $76.2 million, a $4.7 million decline from March 31, 2009 and a $13.9 million decline from December 31, 2008. This decrease is primarily attributable to the operating loss and cash expenses relating to the Company's commitments under its product commercialization contract. As of June 30, 2009, the Company's cash equivalents were predominately invested in Treasury money market funds and the Company had no commercial debt.

Conference Call

As previously announced, PDI will hold a conference call today, to discuss financial and operational results of the second quarter ended June 30, 2009 as follows:

    Time:  4:30 pm (ET)
    Dial-in numbers: 866-644-4654 (U.S. & Canada) or 706-643-1203
    Conference ID#: 22718573
    Live webcast: www.pdi-inc.com

The teleconference replay will be available two hours after completion through Friday, August 7, 2009 by dialing 800-642-1687 (U.S. & Canada) or 706-645-9291 and entering conference ID 22718573. The archived webcast will be available for one year on the Company's investor website, www.pdi-inc.com.

About PDI<
'/>"/>

SOURCE PDI, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
2. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
3. NxStage Reports Second Quarter 2009 Financial Results
4. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
5. Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
6. CuraGen Reports Second Quarter 2009 Financial Results
7. ERT Reports Second Quarter 2009 Results
8. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
9. Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
10. Caliper Life Sciences Reports Second Quarter 2009 Results
11. Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Genedata, a leading provider ... and related life science research, today announced ... Selector as its host-pathogen data analysis platform ... a European consortium dedicated to improving the ... anti-fungal drug therapies. Genedata Selector supports this ...
(Date:9/30/2014)... MAR, Calif. , Sept. 30, 2014 ... for women,s health announces its receipt of a patent ... FemmyCycle menstrual cup has also received FDA clearance in ... Canada, and the CE in Europe. This patent is related ... conjunction with this issuance, the company is releasing FemmyCycle ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Lyme ... funder of Lyme disease research at universities, today announced ... focused on the identification, treatment and cure for Lyme ... had received the most applications in its history—over 20 ... , “While we were pleased to receive so many ...
(Date:9/30/2014)... 30, 2014 UFP Technologies, a ... packaging has recently introduced a custom insulated shipping ... . The new insulated shipper solves the issue ... process. UFP Technologies’ BioShell is a universal storage ... storage, handling and shipping. The insulated shipper keeps ...
Breaking Biology Technology:FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3The FemmyCycle 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 2UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 3
... and Technology (NIST) and The Johns Hopkins University ... properties of promising new materials with unprecedented sensitivity ... most useful for nanotechnology and industrial applications. , ... (MACS), is a variation on several other spectrometers ...
... N.C., Feb. 25 Cornerstone Therapeutics Inc. (Nasdaq: ... developing and commercializing prescription medications for respiratory disorders, today ... 8:30 AM ET on Thursday, March 26, 2009, to ... ended December 31, 2008. Management will also provide ...
... VINELAND, ON, Feb. 25 /PRNewswire/ - How does a ... to answer that question with its model for the ... horticulture science cluster in Canada, industry will steer the ... Jim Brandle, C.E.O. Vineland Research and Innovation Centre. "And ...
Cached Biology Technology:Nanotechnologists gain powerful new materials probe 2Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call 2Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call 3Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call 4Vineland Enables Industries' Efforts to Build Agri-Science Research Cluster 2
(Date:9/30/2014)... Ill. (September 30, 2014) People who suffer from ... do to control their asthma besides properly taking medications ... new article in the Annals of Allergy, Asthma ... College of Allergy, Asthma and Immunology (ACAAI), asthma sufferers ... their lifestyle. The woman described in the Annals article ...
(Date:9/29/2014)... Between 1970 and 2010 populations of mammals, birds, ... 52 percent, says the 2014 Living Planet Report ... biodiversity loss occurs disproportionately in low-income countriesand correlates ... , In addition to the precipitous decline in ... warning signs about the overall health of the ...
(Date:9/29/2014)... In order to support the world,s needs ... polymers and more, new and more efficient catalytic ... of researchers, including several from Wayne State University, ... a new grant from the National Science Foundation. ... Design of Multicomponent Materials for Electrocatalytic Cascade Reactions," ...
Breaking Biology News(10 mins):Asthma symptoms kicking up? Check your exposure to air pollution 2Half of global wildlife lost, says new WWF report 2Wayne State research aims to develop new, more efficient catalytic materials 2
... Investigators have discovered that some type of protective system ... immune system is deficient. This discovery indicates a hidden ... diseases of the immune system such as AIDS. The ... and Baltimore, and is reported in the early online ...
... Medical Center have uncovered part of the genetic mechanism that ... , A team led by SFVAMC vascular surgeon Rajabrata Sarkar, ... is essential for the growth of new arteries when the ... identified and described, for the first time, the specific DNA ...
... in Brazil 40 years ago, Marc A. Meyers marveled at ... on the forest floor. Now a materials scientist and professor ... Engineering, Meyers said makers of airplanes and automobiles may benefit ... conducted in his lab. , "Our computer modeling done shows ...
Cached Biology News:Infant transplant patients resist infections that kill adult AIDS patients 2Infant transplant patients resist infections that kill adult AIDS patients 3Genetic key to growth of new arteries is identified 2Genetic key to growth of new arteries is identified 3Engineers discover why toucan beaks are models of lightweight strength 2
... The FailSafe™ PCR System is the ... the first time and every time. It ... regardless of the source or the property ... EPICENTRE's FailSafe™ PCR Enzyme Mix, a unique ...
... Linkage: This CLS number ... created to easily match Cornings ... availability yet, please order under ... or contact customer service for ...
... the denaturation and hybridization steps in slide-based ... clinical and research personnel. The low cost ... types, is easy to use, and reduces ... ensuring overall precision and accuracy in all ...
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition...
Biology Products: